Evaluation of therapeutic effect of Iranian natural honey on H. pylori infection

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20151106024901N4

Enrollment

200

Registered

2021-03-24

Start date

2021-02-08

Completion date

Unknown

Last updated

2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric or duodenal ulcers. Gastric ulcer

Interventions

Intervention 1: Intervention group: omeprazole capsules 20 mg daily, clarithromycin 500 mg tablets every 12 hours, bismuth tablets 2 tablets daily and amoxicillin capsules 1 gram every 12 hours and Ir

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Refer to the gastrointestinal clinic of Shahid Beheshti Hospital in Kashan Endoscopic and biopsy-confirmed peptic ulcer or gastritis Infection with Helicobacter Pylori infection confirmed by biopsy and fecal antigen test

Exclusion criteria

Exclusion criteria: Reluctance to participate in the project Previous history of treatment for Helicobacter pylori Having diabetes mellitus Existence of gastrointestinal anomalies

Design outcomes

Primary

Measure	Time frame
Helicobacter pylori eradication. Timepoint: Before treatment, 4 weeks after the end of treatment. Method of measurement: Stool antigen test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyed Mahdi Rasuli Manesh

Kashan University of Medical Sciences

m_rasulimanesh@kaums.ac.ir+98 31 5554 0021

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026